Related Experiment Video

Updated: Aug 29, 2026

Establishment and Characterization of UTI and CAUTI in a Mouse Model
08:40

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Published on: June 23, 2015

Pediatric urinary tract infections: the role of fluoroquinolones

Martin A Koyle1, Albaha Barqawi, Jodi Wild

  • 1Department of Pediatric Urology, The Children's Hospital, Denver, CO 80218, USA. marty.koyle@uchsc.edu

The Pediatric Infectious Disease Journal
|December 23, 2003
PubMed

Insights

Pediatric urinary tract infections (UTIs) are often complicated. Oral fluoroquinolones show promise for treating complicated pediatric UTIs, offering a convenient and potentially safe option.

Area of Science:

  • Pediatric Nephrology
  • Infectious Diseases
  • Pharmacology

Background:

  • Urinary tract infections (UTIs) are common in children.
  • Pediatric UTIs are frequently complicated by structural anomalies or dysfunctional elimination.
  • Effective UTI treatment is crucial to prevent renal damage and long-term complications.

Purpose of the Study:

  • To evaluate the efficacy and safety of oral fluoroquinolones for treating complicated pediatric UTIs.
  • To explore the potential of oral antimicrobials as a convenient alternative to parenteral therapy in children.

Main Methods:

  • Review of existing data on fluoroquinolone use in pediatric UTIs.
  • Assessment of clinical efficacy and safety profiles.
  • Consideration of oral versus parenteral treatment options.

Main Results:

  • Limited data suggest oral fluoroquinolones are likely effective for pediatric UTIs.
  • Safety considerations are paramount when using fluoroquinolones in children.
  • Oral antimicrobials offer convenience if efficacy and safety are confirmed.

Conclusions:

  • Oral fluoroquinolones represent a potential treatment option for complicated pediatric UTIs.
  • Further investigation is needed to fully establish the role and safety of fluoroquinolones in this population.
  • Balancing efficacy, safety, and convenience is key for pediatric UTI management.

More Related Videos

Longitudinal Follow-Up of Urinary Tract Infections and Their Treatment in Mice using Bioluminescence Imaging07:39

Longitudinal Follow-Up of Urinary Tract Infections and Their Treatment in Mice using Bioluminescence Imaging

Published on: June 14, 2021

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs like...
Urinary Tract Infection I: Introduction01:26

Urinary Tract Infection I: Introduction

Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...